Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Cascao, R., Fonseca, J
In L929 cells, wound closure after 12 hours reached 83% with GHK-AgNPs and 76% with GHK-Cu-AgNPs
The FDA has restored GHK-Cu for non-injectable use to Category 1 of its 503A bulk drug substances list, reversing an April 22, 2026 removal that compounding pharmacies had been scrambling to interpret for the better part of a month
J Gen Appl Microbiol 3:193205
Available in an easily measured lyophilized powder form for the lab
AOD-9604 adds a lipolytic component without further IGF-1 increase , useful in research contexts where you want lipolysis but not systemic anabolism
US$ 27.21
US$ 26.32
US$ 20.90
US$ 24.41
.png&w=3840&q=75)
US$ 23.26
US$ 27.35
US$ 20.33
US$ 24.04
